Improvement in corneal scarring following bacterial keratitis
Aim Bacterial keratitis results in corneal scarring and subsequent visual impairment. The long-term evolution of corneal scars has not been well described. In this case series, we identified patients who had improvement in corneal scarring and visual acuity from a clinical trial for bacterial kerati...
Gespeichert in:
Veröffentlicht in: | Eye (London) 2013-03, Vol.27 (3), p.443-446 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 446 |
---|---|
container_issue | 3 |
container_start_page | 443 |
container_title | Eye (London) |
container_volume | 27 |
creator | McClintic, S M Srinivasan, M Mascarenhas, J Greninger, D A Acharya, N R Lietman, T M Keenan, J D |
description | Aim
Bacterial keratitis results in corneal scarring and subsequent visual impairment. The long-term evolution of corneal scars has not been well described. In this case series, we identified patients who had improvement in corneal scarring and visual acuity from a clinical trial for bacterial keratitis.
Methods
We searched the records of the Steroids for Corneal Ulcers Trial (SCUT) for patients who had improvement in vision between the 3-month and 12-month visits and reviewed their clinical photographs.
Results
Of the 500 patients enrolled in SCUT, five patients with large central corneal scars due to bacterial keratitis are presented. All experienced improvement in rigid contact lens–corrected visual acuity from months 3 to 12. All patients also had marked improvement in corneal opacity during the same time period. None of the patients opted to have penetrating keratoplasty.
Conclusions
Corneal scars may continue to improve even many months after a bacterial corneal ulcer has healed. The corneal remodeling can be accompanied by considerable improvement in visual acuity, such that corneal transplantation may not be necessary. |
doi_str_mv | 10.1038/eye.2012.270 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3597874</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1317408897</sourcerecordid><originalsourceid>FETCH-LOGICAL-c483t-2b2854263d45c2158c29f11533439e704ee1bb2a6aa2fe62ef6ed98541b982ea3</originalsourceid><addsrcrecordid>eNqNkc9LHDEUx4NU6mp781wWeunBWZOXZJI5tFDEHwsLXlroLWSyb7bRmcmazFr8782wKqv04CEk8D755uV9CDlmdMYo16f4gDOgDGag6B6ZMKHKQgopPpAJrSQtAODPATlM6YbSXFT0IzkADlwLwSfk-7xbx3CPHfbD1PdTF2KPtp0mZ2P0_WrahLYN_8ZTbd2A0efiLUY7-MGnT2S_sW3Cz0_7Efl9cf7r7KpYXF_Oz34uCic0HwqoQUsBJV8K6YBJ7aBqGJOcC16hogKR1TXY0lposARsSlxW-QqrKw1o-RH5sc1db-oOly43G21r1tF3Nj6YYL15Xen9X7MK94bLSmklcsC3p4AY7jaYBtP55LBtbY9hkwwbB0KVKst3oEwJqnWlMvr1DXoTNrHPkxipUuUldaZOtpSLIaWIzUvfjJpRockKzajQZIUZ_7L71xf42VkGii2Q1qMhjDuv_i_wEfHipdc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1316731658</pqid></control><display><type>article</type><title>Improvement in corneal scarring following bacterial keratitis</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>SpringerLink Journals - AutoHoldings</source><creator>McClintic, S M ; Srinivasan, M ; Mascarenhas, J ; Greninger, D A ; Acharya, N R ; Lietman, T M ; Keenan, J D</creator><creatorcontrib>McClintic, S M ; Srinivasan, M ; Mascarenhas, J ; Greninger, D A ; Acharya, N R ; Lietman, T M ; Keenan, J D</creatorcontrib><description>Aim
Bacterial keratitis results in corneal scarring and subsequent visual impairment. The long-term evolution of corneal scars has not been well described. In this case series, we identified patients who had improvement in corneal scarring and visual acuity from a clinical trial for bacterial keratitis.
Methods
We searched the records of the Steroids for Corneal Ulcers Trial (SCUT) for patients who had improvement in vision between the 3-month and 12-month visits and reviewed their clinical photographs.
Results
Of the 500 patients enrolled in SCUT, five patients with large central corneal scars due to bacterial keratitis are presented. All experienced improvement in rigid contact lens–corrected visual acuity from months 3 to 12. All patients also had marked improvement in corneal opacity during the same time period. None of the patients opted to have penetrating keratoplasty.
Conclusions
Corneal scars may continue to improve even many months after a bacterial corneal ulcer has healed. The corneal remodeling can be accompanied by considerable improvement in visual acuity, such that corneal transplantation may not be necessary.</description><identifier>ISSN: 0950-222X</identifier><identifier>EISSN: 1476-5454</identifier><identifier>DOI: 10.1038/eye.2012.270</identifier><identifier>PMID: 23238443</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/699 ; 692/699/255/1318 ; 692/700/565/545/576 ; Acuity ; Adult ; Aged ; Aza Compounds - therapeutic use ; Bacteria ; Case Series ; Cicatrix - physiopathology ; Clinical trials ; Cornea ; Corneal Ulcer - drug therapy ; Corneal Ulcer - microbiology ; Corneal Ulcer - physiopathology ; Evolution ; Eye ; Eye Infections, Bacterial - drug therapy ; Eye Infections, Bacterial - microbiology ; Eye Infections, Bacterial - physiopathology ; Female ; Fluoroquinolones ; Humans ; Keratitis ; Laboratory Medicine ; Male ; Medicine ; Medicine & Public Health ; Middle Aged ; Ophthalmic Solutions ; Ophthalmology ; Pharmaceutical Sciences/Technology ; Pneumococcal Infections - drug therapy ; Pneumococcal Infections - microbiology ; Pneumococcal Infections - physiopathology ; Prednisolone - analogs & derivatives ; Prednisolone - therapeutic use ; Pseudomonas Infections - drug therapy ; Pseudomonas Infections - microbiology ; Pseudomonas Infections - physiopathology ; Quinolines - therapeutic use ; Steroid hormones ; Surgery ; Surgical Oncology ; Ulcers ; Vision ; Vision Disorders - physiopathology ; Visual Acuity - physiology</subject><ispartof>Eye (London), 2013-03, Vol.27 (3), p.443-446</ispartof><rights>Royal College of Ophthalmologists 2013</rights><rights>Copyright Nature Publishing Group Mar 2013</rights><rights>Copyright © 2013 Royal College of Ophthalmologists 2013 Royal College of Ophthalmologists</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c483t-2b2854263d45c2158c29f11533439e704ee1bb2a6aa2fe62ef6ed98541b982ea3</citedby><cites>FETCH-LOGICAL-c483t-2b2854263d45c2158c29f11533439e704ee1bb2a6aa2fe62ef6ed98541b982ea3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597874/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597874/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,41464,42533,51294,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23238443$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McClintic, S M</creatorcontrib><creatorcontrib>Srinivasan, M</creatorcontrib><creatorcontrib>Mascarenhas, J</creatorcontrib><creatorcontrib>Greninger, D A</creatorcontrib><creatorcontrib>Acharya, N R</creatorcontrib><creatorcontrib>Lietman, T M</creatorcontrib><creatorcontrib>Keenan, J D</creatorcontrib><title>Improvement in corneal scarring following bacterial keratitis</title><title>Eye (London)</title><addtitle>Eye</addtitle><addtitle>Eye (Lond)</addtitle><description>Aim
Bacterial keratitis results in corneal scarring and subsequent visual impairment. The long-term evolution of corneal scars has not been well described. In this case series, we identified patients who had improvement in corneal scarring and visual acuity from a clinical trial for bacterial keratitis.
Methods
We searched the records of the Steroids for Corneal Ulcers Trial (SCUT) for patients who had improvement in vision between the 3-month and 12-month visits and reviewed their clinical photographs.
Results
Of the 500 patients enrolled in SCUT, five patients with large central corneal scars due to bacterial keratitis are presented. All experienced improvement in rigid contact lens–corrected visual acuity from months 3 to 12. All patients also had marked improvement in corneal opacity during the same time period. None of the patients opted to have penetrating keratoplasty.
Conclusions
Corneal scars may continue to improve even many months after a bacterial corneal ulcer has healed. The corneal remodeling can be accompanied by considerable improvement in visual acuity, such that corneal transplantation may not be necessary.</description><subject>692/699</subject><subject>692/699/255/1318</subject><subject>692/700/565/545/576</subject><subject>Acuity</subject><subject>Adult</subject><subject>Aged</subject><subject>Aza Compounds - therapeutic use</subject><subject>Bacteria</subject><subject>Case Series</subject><subject>Cicatrix - physiopathology</subject><subject>Clinical trials</subject><subject>Cornea</subject><subject>Corneal Ulcer - drug therapy</subject><subject>Corneal Ulcer - microbiology</subject><subject>Corneal Ulcer - physiopathology</subject><subject>Evolution</subject><subject>Eye</subject><subject>Eye Infections, Bacterial - drug therapy</subject><subject>Eye Infections, Bacterial - microbiology</subject><subject>Eye Infections, Bacterial - physiopathology</subject><subject>Female</subject><subject>Fluoroquinolones</subject><subject>Humans</subject><subject>Keratitis</subject><subject>Laboratory Medicine</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Ophthalmic Solutions</subject><subject>Ophthalmology</subject><subject>Pharmaceutical Sciences/Technology</subject><subject>Pneumococcal Infections - drug therapy</subject><subject>Pneumococcal Infections - microbiology</subject><subject>Pneumococcal Infections - physiopathology</subject><subject>Prednisolone - analogs & derivatives</subject><subject>Prednisolone - therapeutic use</subject><subject>Pseudomonas Infections - drug therapy</subject><subject>Pseudomonas Infections - microbiology</subject><subject>Pseudomonas Infections - physiopathology</subject><subject>Quinolines - therapeutic use</subject><subject>Steroid hormones</subject><subject>Surgery</subject><subject>Surgical Oncology</subject><subject>Ulcers</subject><subject>Vision</subject><subject>Vision Disorders - physiopathology</subject><subject>Visual Acuity - physiology</subject><issn>0950-222X</issn><issn>1476-5454</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqNkc9LHDEUx4NU6mp781wWeunBWZOXZJI5tFDEHwsLXlroLWSyb7bRmcmazFr8782wKqv04CEk8D755uV9CDlmdMYo16f4gDOgDGag6B6ZMKHKQgopPpAJrSQtAODPATlM6YbSXFT0IzkADlwLwSfk-7xbx3CPHfbD1PdTF2KPtp0mZ2P0_WrahLYN_8ZTbd2A0efiLUY7-MGnT2S_sW3Cz0_7Efl9cf7r7KpYXF_Oz34uCic0HwqoQUsBJV8K6YBJ7aBqGJOcC16hogKR1TXY0lposARsSlxW-QqrKw1o-RH5sc1db-oOly43G21r1tF3Nj6YYL15Xen9X7MK94bLSmklcsC3p4AY7jaYBtP55LBtbY9hkwwbB0KVKst3oEwJqnWlMvr1DXoTNrHPkxipUuUldaZOtpSLIaWIzUvfjJpRockKzajQZIUZ_7L71xf42VkGii2Q1qMhjDuv_i_wEfHipdc</recordid><startdate>20130301</startdate><enddate>20130301</enddate><creator>McClintic, S M</creator><creator>Srinivasan, M</creator><creator>Mascarenhas, J</creator><creator>Greninger, D A</creator><creator>Acharya, N R</creator><creator>Lietman, T M</creator><creator>Keenan, J D</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>7QL</scope><scope>C1K</scope><scope>5PM</scope></search><sort><creationdate>20130301</creationdate><title>Improvement in corneal scarring following bacterial keratitis</title><author>McClintic, S M ; Srinivasan, M ; Mascarenhas, J ; Greninger, D A ; Acharya, N R ; Lietman, T M ; Keenan, J D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c483t-2b2854263d45c2158c29f11533439e704ee1bb2a6aa2fe62ef6ed98541b982ea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>692/699</topic><topic>692/699/255/1318</topic><topic>692/700/565/545/576</topic><topic>Acuity</topic><topic>Adult</topic><topic>Aged</topic><topic>Aza Compounds - therapeutic use</topic><topic>Bacteria</topic><topic>Case Series</topic><topic>Cicatrix - physiopathology</topic><topic>Clinical trials</topic><topic>Cornea</topic><topic>Corneal Ulcer - drug therapy</topic><topic>Corneal Ulcer - microbiology</topic><topic>Corneal Ulcer - physiopathology</topic><topic>Evolution</topic><topic>Eye</topic><topic>Eye Infections, Bacterial - drug therapy</topic><topic>Eye Infections, Bacterial - microbiology</topic><topic>Eye Infections, Bacterial - physiopathology</topic><topic>Female</topic><topic>Fluoroquinolones</topic><topic>Humans</topic><topic>Keratitis</topic><topic>Laboratory Medicine</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Ophthalmic Solutions</topic><topic>Ophthalmology</topic><topic>Pharmaceutical Sciences/Technology</topic><topic>Pneumococcal Infections - drug therapy</topic><topic>Pneumococcal Infections - microbiology</topic><topic>Pneumococcal Infections - physiopathology</topic><topic>Prednisolone - analogs & derivatives</topic><topic>Prednisolone - therapeutic use</topic><topic>Pseudomonas Infections - drug therapy</topic><topic>Pseudomonas Infections - microbiology</topic><topic>Pseudomonas Infections - physiopathology</topic><topic>Quinolines - therapeutic use</topic><topic>Steroid hormones</topic><topic>Surgery</topic><topic>Surgical Oncology</topic><topic>Ulcers</topic><topic>Vision</topic><topic>Vision Disorders - physiopathology</topic><topic>Visual Acuity - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McClintic, S M</creatorcontrib><creatorcontrib>Srinivasan, M</creatorcontrib><creatorcontrib>Mascarenhas, J</creatorcontrib><creatorcontrib>Greninger, D A</creatorcontrib><creatorcontrib>Acharya, N R</creatorcontrib><creatorcontrib>Lietman, T M</creatorcontrib><creatorcontrib>Keenan, J D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Eye (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McClintic, S M</au><au>Srinivasan, M</au><au>Mascarenhas, J</au><au>Greninger, D A</au><au>Acharya, N R</au><au>Lietman, T M</au><au>Keenan, J D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Improvement in corneal scarring following bacterial keratitis</atitle><jtitle>Eye (London)</jtitle><stitle>Eye</stitle><addtitle>Eye (Lond)</addtitle><date>2013-03-01</date><risdate>2013</risdate><volume>27</volume><issue>3</issue><spage>443</spage><epage>446</epage><pages>443-446</pages><issn>0950-222X</issn><eissn>1476-5454</eissn><abstract>Aim
Bacterial keratitis results in corneal scarring and subsequent visual impairment. The long-term evolution of corneal scars has not been well described. In this case series, we identified patients who had improvement in corneal scarring and visual acuity from a clinical trial for bacterial keratitis.
Methods
We searched the records of the Steroids for Corneal Ulcers Trial (SCUT) for patients who had improvement in vision between the 3-month and 12-month visits and reviewed their clinical photographs.
Results
Of the 500 patients enrolled in SCUT, five patients with large central corneal scars due to bacterial keratitis are presented. All experienced improvement in rigid contact lens–corrected visual acuity from months 3 to 12. All patients also had marked improvement in corneal opacity during the same time period. None of the patients opted to have penetrating keratoplasty.
Conclusions
Corneal scars may continue to improve even many months after a bacterial corneal ulcer has healed. The corneal remodeling can be accompanied by considerable improvement in visual acuity, such that corneal transplantation may not be necessary.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>23238443</pmid><doi>10.1038/eye.2012.270</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0950-222X |
ispartof | Eye (London), 2013-03, Vol.27 (3), p.443-446 |
issn | 0950-222X 1476-5454 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3597874 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; SpringerLink Journals - AutoHoldings |
subjects | 692/699 692/699/255/1318 692/700/565/545/576 Acuity Adult Aged Aza Compounds - therapeutic use Bacteria Case Series Cicatrix - physiopathology Clinical trials Cornea Corneal Ulcer - drug therapy Corneal Ulcer - microbiology Corneal Ulcer - physiopathology Evolution Eye Eye Infections, Bacterial - drug therapy Eye Infections, Bacterial - microbiology Eye Infections, Bacterial - physiopathology Female Fluoroquinolones Humans Keratitis Laboratory Medicine Male Medicine Medicine & Public Health Middle Aged Ophthalmic Solutions Ophthalmology Pharmaceutical Sciences/Technology Pneumococcal Infections - drug therapy Pneumococcal Infections - microbiology Pneumococcal Infections - physiopathology Prednisolone - analogs & derivatives Prednisolone - therapeutic use Pseudomonas Infections - drug therapy Pseudomonas Infections - microbiology Pseudomonas Infections - physiopathology Quinolines - therapeutic use Steroid hormones Surgery Surgical Oncology Ulcers Vision Vision Disorders - physiopathology Visual Acuity - physiology |
title | Improvement in corneal scarring following bacterial keratitis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T19%3A43%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Improvement%20in%20corneal%20scarring%20following%20bacterial%20keratitis&rft.jtitle=Eye%20(London)&rft.au=McClintic,%20S%20M&rft.date=2013-03-01&rft.volume=27&rft.issue=3&rft.spage=443&rft.epage=446&rft.pages=443-446&rft.issn=0950-222X&rft.eissn=1476-5454&rft_id=info:doi/10.1038/eye.2012.270&rft_dat=%3Cproquest_pubme%3E1317408897%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1316731658&rft_id=info:pmid/23238443&rfr_iscdi=true |